UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could tame eye inflammation and save sight
Disease control OngoingThis study tests an oral medication called brepocitinib for people with active uveitis (inflammation inside the eye) that is not caused by an infection. The goal is to see if the drug can control the inflammation and prevent vision loss. About 371 adults aged 18-75 with intermedi…
Matched conditions: UVEITIS
Phase: PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
New hope for kids with Arthritis-Related eye disease: baricitinib trial shows promise
Disease control OngoingThis study tests an oral drug called baricitinib in children aged 2 to 18 with active uveitis (eye inflammation) linked to juvenile idiopathic arthritis or a related condition. The goal is to see if baricitinib can safely reduce eye inflammation better than current treatments. Ab…
Matched conditions: UVEITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New imaging tool could sharpen uveitis treatment decisions
Knowledge-focused OngoingThis study tests a new imaging method to measure eye inflammation in people with uveitis. Researchers will see if the scores from this imaging can help doctors decide on treatment. The study involves 50 patients with active or recent eye inflammation.
Matched conditions: UVEITIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 07:04 UTC
-
Singapore study digs into eye inflammation patterns
Knowledge-focused OngoingThis study looks back at the medical records of 200 people in Singapore with eye inflammation conditions like uveitis and scleritis. Researchers want to learn who gets these diseases, what treatments they receive, and how they do over time. The goal is to better understand these …
Matched conditions: UVEITIS
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated May 26, 2026 07:00 UTC
-
Eye fluid clues could revolutionize uveitis treatment
Knowledge-focused OngoingThis study looks at whether proteins in eye fluid can help doctors choose the right immunosuppressive drug for people with non-infectious uveitis, a type of eye inflammation. About 220 participants who haven't responded well to steroids will have their eye fluid tested for 14 dif…
Matched conditions: UVEITIS
Phase: NA • Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC